No products in the cart.
Vaccination boosted immunity acquired from previous SARS-CoV-2 infection
1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection again severe acute respiratory syndrome coronary...
Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to severe Covid-19-related infection and medical intervention....
BNT162b2 safe and efficacious in children 5 to 11 years of age
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11 years of...
Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection by more than 50%. 2....
Canadian Syncope Risk Score demonstrates international external validation
1. The Canadian Syncope Risk Score was superior when compared to the Osservatorio Epidemiologico della Sincope nel Lazio (OESIL) score...
Dapagliflozin efficacious and safe in treating heart failure
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of frailty status. 2. Dapagliflozin improved quality...
Nasal high-flow therapy improves likelihood of neonatal intubation
1. In infants undergoing endotracheal intubation, nasal high-flow therapy improved the likelihood of successful intubation on the first attempt. 2....
Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to...
Respiratory syncytial virus (RSV) vaccine produces transplacental neutralizing antibodies in pregnant women
1. The prefusion F protein of RSV (RSVpreF) vaccine produces neutralizing antibodies against RSV in both the serum of the...
CT associated with lower complication risks than invasive coronary angiography
1. In patients with stable chest pain and intermediate pretest probability of coronary artery disease (CAD), there was no difference...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.